Amgen signs DaVita, Fresenius anemia drug deals - Reuters PDF Print
Reuters
(Reuters) - Amgen Inc, aiming to secure future sales of its flagship anemia drug Epogen as potential competition emerges, has reached new supply contracts with the two largest operators of US kidney dialysis clinics.

...

 
Share |
Copyright © 2025 Global Dialysis. All Rights Reserved.